NEW YORK, July 04, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sarepta Therapeutics, Inc. (“Sarepta” or “the Company”) (NASDAQ: SRPT) and certain of its officers.
TORONTO, July 04, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that it has filed a preliminary short form base shelf prospectus with the securities regulatory authorities in each of the provinces of Canada, except Québec (the “Securities Regulators”).
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) between June 22, 2023 and June 24, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 25, 2025.
WASHINGTON, July 3, 2025 /PRNewswire/ -- The Early Care and Education Consortium (ECEC) applauds Congress for including $16 billion in child care tax incentives...
MUMBAI, India, July 3, 2025 /PRNewswire/ -- Bound, India's leading creative education platform, announces the next edition of The Bound Publishing Course, a first-of-its-kind,...
Recognized for its biotech-first focus, innovation in clinical trial delivery, and best-in-class client experience, Novotech sets the global standard in contract research for biotechs...
Recognized for its biotech-first focus, innovation in clinical trial delivery, and best-in-class client experience, Novotech sets the global standard in contract research for biotechs...
Veteran-Owned Franchise Owners Honored at PuroVet Forum; Convention Includes Tribute to Frank Torre Sr. and Moving Ceremony Led by Color Guard
TAMARAC, Fla., July 2,...
NEW DELHI, July 2, 2025 /PRNewswire/ -- In an age where one manipulated image can ignite social unrest, sway elections, or defame reputations, the demand...
NEW DELHI, July 2, 2025 /PRNewswire/ -- In an age where one manipulated image can ignite social unrest, sway elections, or defame reputations, the demand...
SCOTTSDALE, Ariz., July 2, 2025 /PRNewswire/ -- As the nation marks Social Wellness Month this July, Executive Home Care is inviting purpose-driven entrepreneurs to...
SHREWSBURY, United Kingdom, July 02, 2025 (GLOBE NEWSWIRE) -- Lightchain AI, an AI-native decentralized infrastructure platform, today announced the start of its Final Bonus Phase, following the successful completion of all 15 presale stages and the achievement of a major milestone—$21.1 million raised from a global community of early contributors. This final round offers a fixed price of $0.007125 per LCAI token, providing one last opportunity for participants ahead of the mainnet launch scheduled for July 2025.
Recruitment initiated into the Phase 2 opaganib plus darolutamide study in patients with advanced prostate cancer, sponsored by ANZUP, and supported by Bayer and...